Jae B. Kim
Chief Tech/Sci/R&D Officer chez DESIGN THERAPEUTICS, INC.
Fortune : 19 167 $ au 31/03/2024
Profil
Jae B.
Kim is currently the Chief Medical Officer at Design Therapeutics, Inc. Prior to this, he was the Chief Medical Officer at Avidity Biosciences, Inc. from 2020 to 2021 and the Vice President-Clinical Development at Alnylam Pharmaceuticals, Inc. from 2016 to 2020.
Dr. Kim received his undergraduate degree from Cornell University and his doctorate from Weill Cornell Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/03/2024 | 4 756 ( 0,01% ) | 19 167 $ | 31/03/2024 |
Postes actifs de Jae B. Kim
| Sociétés | Poste | Début |
|---|---|---|
| DESIGN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/02/2022 |
Anciens postes connus de Jae B. Kim
| Sociétés | Poste | Fin |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 30/08/2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2020 |
Formation de Jae B. Kim
| Cornell University | Undergraduate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Design Therapeutics, Inc. |
